Cahill Brian Joseph bought EGRX
February 27, 2024 · Form 4 insider transaction
Cahill Brian Joseph bought 3,800 shares of Eagle Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,800
Price
$0.00
Total value
N/A
InsiderCahill Brian Joseph
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2024
Filing dateFebruary 29, 2024
Shares owned after49,547
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents common stock issued upon satisfaction of certain performance criteria contained in performance stock units ("PSUs") granted in 2021.